107 related articles for article (PubMed ID: 1376454)
1. Recovery from unilateral 6-hydroxydopamine lesion of substantia nigra promoted by the neurotachykinin substance P 1-11.
Mattioli R; Schwarting RK; Huston JP
Neuroscience; 1992; 48(3):595-605. PubMed ID: 1376454
[TBL] [Abstract][Full Text] [Related]
2. Pretreatment with neurokinin substance P but not with cholecystokinin-8S can alleviate functional deficits of partial nigrostriatal 6-hydroxydopamine lesion.
Nikolaus S; Huston JP; Körber B; Thiel C; Schwarting RK
Peptides; 1997; 18(8):1161-8. PubMed ID: 9396056
[TBL] [Abstract][Full Text] [Related]
3. Behavioral asymmetries and neurochemical changes after unilateral lesions of tuberomammillary nucleus or substantia nigra.
Maisonnette S; Huston JP; Brandao M; Schwarting RK
Exp Brain Res; 1998 Jun; 120(3):273-82. PubMed ID: 9628414
[TBL] [Abstract][Full Text] [Related]
4. Pretreatment with fragments of substance-P or with cholecystokinin differentially affects recovery from sub-total nigrostriatal 6-hydroxydopamine lesion.
Nikolaus S; Huston JP; Schwarting RK
Neural Plast; 1999; 6(4):77-89. PubMed ID: 10714262
[TBL] [Abstract][Full Text] [Related]
5. Behavioral indices of moderate nigro-striatal 6-hydroxydopamine lesion: a preclinical Parkinson's model.
Fornaguera J; Schwarting RK; Boix F; Huston JP
Synapse; 1993 Feb; 13(2):179-85. PubMed ID: 7680495
[TBL] [Abstract][Full Text] [Related]
6. Relationship of changes in spontaneous motor activity to spontaneous circling in rats with unilateral 6-hydroxydopamine lesions of the substantia nigra.
Carey RJ
Exp Neurol; 1986 Jun; 92(3):591-600. PubMed ID: 3086112
[TBL] [Abstract][Full Text] [Related]
7. Spontaneous recovery from motor asymmetry in adult rats with 6-hydroxydopamine-induced partial lesions of the substantia nigra.
Dravid A; Jaton AL; Enz A; Frei P
Brain Res; 1984 Oct; 311(2):361-5. PubMed ID: 6149789
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of brain-derived neurotrophic factor and neurotrophin-3 on neurochemical and behavioral deficits associated with partial nigrostriatal dopamine lesions.
Altar CA; Boylan CB; Fritsche M; Jones BE; Jackson C; Wiegand SJ; Lindsay RM; Hyman C
J Neurochem; 1994 Sep; 63(3):1021-32. PubMed ID: 7519657
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of tachykinins injected intranigrally on striatal dopamine metabolism.
Tan DP; Tsou K
J Neurochem; 1988 Nov; 51(5):1333-7. PubMed ID: 2459306
[TBL] [Abstract][Full Text] [Related]
10. Selective subregional dopamine depletions in the rat caudate-putamen following nigrostriatal lesions.
Pehek EA; Crock R; Yamamoto BK
Synapse; 1992 Apr; 10(4):317-25. PubMed ID: 1374937
[TBL] [Abstract][Full Text] [Related]
11. Sparing of behavior and basal extracellular dopamine after 6-hydroxydopamine lesions of the nigrostriatal pathway in rats exposed to a prelesion sensitizing regimen of amphetamine.
Moroz IA; Peciña S; Schallert T; Stewart J
Exp Neurol; 2004 Sep; 189(1):78-93. PubMed ID: 15296838
[TBL] [Abstract][Full Text] [Related]
12. Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats.
Robinson TE; Whishaw IQ
Brain Res; 1988 May; 450(1-2):209-24. PubMed ID: 3135914
[TBL] [Abstract][Full Text] [Related]
13. Differential cholinergic and non-cholinergic actions of acetylcholinesterase in the substantia nigra revealed by fasciculin-induced inhibition.
Dajas F; Silveira R; Costa G; Castello ME; Jerusalinsky D; Medina J; Levesque D; Greenfield S
Brain Res; 1993 Jul; 616(1-2):1-5. PubMed ID: 7689409
[TBL] [Abstract][Full Text] [Related]
14. Two kinds of nigrostriatal asymmetry: relationship to dopaminergic drug sensitivity and 6-hydroxydopamine lesion effects in Long-Evans rats.
Glick SD; Hinds PA; Baird JL
Brain Res; 1988 May; 450(1-2):334-41. PubMed ID: 3135915
[TBL] [Abstract][Full Text] [Related]
15. Glial cell line-derived neurotrophic factor attenuates behavioural deficits and regulates nigrostriatal dopaminergic and peptidergic markers in 6-hydroxydopamine-lesioned adult rats: comparison of intraventricular and intranigral delivery.
Lapchak PA; Miller PJ; Collins F; Jiao S
Neuroscience; 1997 May; 78(1):61-72. PubMed ID: 9135089
[TBL] [Abstract][Full Text] [Related]
16. Nigrostriatal dopamine neurons are required to maintain basal levels of substance P in the rat substantia nigra.
Cruz CJ; Beckstead RM
Neuroscience; 1989; 30(2):331-8. PubMed ID: 2473415
[TBL] [Abstract][Full Text] [Related]
17. Serotonergic sprouting is induced by dopamine-lesion in substantia nigra of adult rat brain.
Zhou FC; Bledsoe S; Murphy J
Brain Res; 1991 Aug; 556(1):108-16. PubMed ID: 1718555
[TBL] [Abstract][Full Text] [Related]
18. Modulation of neurotransmitter release by cholecystokinin in the neostriatum and substantia nigra of the rat: regional and receptor specificity.
You ZB; Herrera-Marschitz M; Pettersson E; Nylander I; Goiny M; Shou HZ; Kehr J; Godukhin O; Hökfelt T; Terenius L; Ungerstedt U
Neuroscience; 1996 Oct; 74(3):793-804. PubMed ID: 8884775
[TBL] [Abstract][Full Text] [Related]
19. Relationship between asymmetries in striatal dopamine release and the direction of amphetamine-induced rotation during the first week following a unilateral 6-OHDA lesion of the substantia nigra.
Robinson TE; Noordhoorn M; Chan EM; Mocsary Z; Camp DM; Whishaw IQ
Synapse; 1994 May; 17(1):16-25. PubMed ID: 8042143
[TBL] [Abstract][Full Text] [Related]
20. Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine.
Przedborski S; Levivier M; Jiang H; Ferreira M; Jackson-Lewis V; Donaldson D; Togasaki DM
Neuroscience; 1995 Aug; 67(3):631-47. PubMed ID: 7675192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
